As the winter season persists, bringing along colds, flu, and ongoing concerns about COVID-19, many turn to over-the-counter remedies to alleviate symptoms. However, a recent announcement has put a damper on reliance on one popular brand. On January 24, 2024, Haleon, the manufacturer behind the widely used cough syrup Robitussin, issued a nationwide recall for three of its products due to potential microbial contamination.
Recall Details
The recall, prompted by an alert from the Food and Drug Administration (FDA), affects eight lots of Robitussin Honey CF Max Day and Robitussin Honey CF Max Nighttime syrups. These products, labeled to contain true source-certified honey, are crucial remedies for severe coughs and flu symptoms.
Affected Products:
- Robitussin Honey CF Max Day – Adult 4-ounce
- Lot Number: T10810
- Expiration Date: October 31, 2025
- Robitussin Honey CF Max Day – Adult 8-ounce
- Lot Numbers: T08730, T08731, T08732, T08733, T10808
- Expiration Dates: May 31, 2025 (T08730, T08731, T08732, T08733), September 20, 2025 (T10808)
- Robitussin Honey CF Max NT – Adult 8-ounce
- Lot Numbers: T08740, T08742
- Expiration Date: June 30, 2026
Deep Packet Inspection Market: Thriving Amidst Escalating Cybersecurity Concerns
Potential Risks
The FDA alert emphasizes that while the contaminated products may not pose a significant risk to healthy individuals, those with compromised immune systems could face serious consequences, including fungemia or disseminated fungal infection. To date, no illnesses related to the contamination have been reported.
Consumer Advice
Customers are strongly advised not to consume the recalled products. If individuals suspect they are experiencing adverse reactions, they should promptly seek medical advice. Any adverse reactions should be reported to both the company and the FDA.
Conclusion
As concerns about health and wellness remain paramount, vigilance regarding product safety is essential. The nationwide recall of these cough syrups serves as a reminder of the importance of thorough quality control and the prioritization of consumer safety in the pharmaceutical industry.